Azasite and Blepharitis - a phase IV clinical study of FDA data

Summary:

Blepharitis is reported as a side effect among people who take Azasite (azithromycin), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Tobradex, and have Age-related macular degeneration.

The phase IV clinical study analyzes which people have Blepharitis when taking Azasite. It is created by eHealthMe based on reports of 1,353 people who have side effects when taking Azasite from the FDA, and is updated regularly.

What is Azasite?

Azasite has active ingredients of azithromycin. It is often used in blepharitis. eHealthMe is studying from 1,370 Azasite users. Check the latest studies of Azasite.

What is Blepharitis?

Blepharitis (chronic inflammation of the eyelid) is found to be associated with 513 drugs and 690 conditions by eHealthMe. Check the latest studies of Blepharitis.

On Jul, 05, 2026

1,353 people reported to have side effects when taking Azasite.
Among them, 12 people (0.89%) have Blepharitis.

Among these 12 people:

How long have people been on Azasite when they have Blepharitis? *

What is the gender of people who have Blepharitis when taking Azasite? *

female: 41.67 %
male: 58.33 %

What is the age of people who have Blepharitis when taking Azasite? *

What are other drugs people take besides Azasite? *

What are other side effects people have besides Blepharitis? *

Foreign Body Sensation In Eyes (feeling of something in eye): 3 people, 25.00%
Conjunctival Hyperaemia (congestion of conjunctival vessels): 2 people, 16.67%
Fall: 2 people, 16.67%
Eyelids Pruritus (eyelids itching): 2 people, 16.67%
Eyelid Oedema (eyelids are swollen and contain excessive fluid): 2 people, 16.67%
Hypersensitivity: 2 people, 16.67%
Eye Pruritus (eye itching): 2 people, 16.67%
Eye Irritation: 2 people, 16.67%
Eye Discharge: 2 people, 16.67%
Iris Atrophy (depigmentation or hypopigmentation on the surface of the iris): 2 people, 16.67%

What are the existing conditions these people have? *

Age-Related Macular Degeneration: 2 people, 16.67%
Urinary Tract Infection: 1 person, 8.33%
Ulcerative Keratitis (ulcerative inflammation of the cornea): 1 person, 8.33%
Sinusitis (inflammation of sinus): 1 person, 8.33%
Ocular Hyperaemia (an abnormally large amount of blood in eye): 1 person, 8.33%
Hypersensitivity: 1 person, 8.33%
Eye Irritation: 1 person, 8.33%
Dry Eyes (lack of adequate tears): 1 person, 8.33%
Conjunctivitis Bacterial (infection of conjunctiva by bacteria): 1 person, 8.33%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Azasite and have Blepharitis?

- Check whether Blepharitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Azasite:

Azasite (1,370 reports)

Blepharitis treatments and more:

Blepharitis (5,399 reports)

Browse all side effects of Azasite:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blepharitis:

Blepharitis (513 drugs)

Browse all the conditions that are associated with Blepharitis:

Blepharitis (690 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on azithromycin (the active ingredients of Azasite) and Azasite (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.